Fundraising Fox
Diffuse Bio
YC W23San Francisco, US · Founded 2022 · 10 employees · Hiring · 4 known investors
Find your way into Diffuse Bio
Sign up to see every warm intro you have to Diffuse Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diffuse Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Diffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.
AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoveryDeep LearningGenerative AIMachine LearningUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W23)
Diffuse Bio was founded in 2022 by Namrata Anand.
NA
Namrata AnandFounderNamrata Anand is a bioengineer and computer scientist who has worked on machine learning applications in biology, including computational protein design using AI techniques and diffusion models for protein structure prediction.
SJ
Sebastian JaramilloOperations Specialist
EP
Emily PennellOperations Leadformer
Investors · 4
GreatPoint Ventureslisted by GreatPoint VenturesSan Francisco · $250K – $20M
How we know: GreatPoint Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
.jpeg){kind=logo}
Humba Ventureslisted by Humba VenturesSan Francisco · $750K – $1.5M
How we know: Humba Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
Y Combinatorlisted by Y CombinatorSan Francisco · $500K
How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Related companies · 9
Numerion LabsNumerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.
BodyBioBodyBio is a third-generation family business that develops and manufactures science-backed dietary supplements and vitamins, including phosphatidylcholine (PC), butyrate, and detox products, aimed at cellular health and wellness. Products are made at the company's in-house facility with third-party testing.
MacromoltekMacromoltek provides computational modeling and AI-driven antibody design services to biotech and pharmaceutical companies, accelerating the discovery and optimization of therapeutic antibodies. The platform reduces time-to-market and increases the probability of clinical success in drug development.
Reverie LabsReverie Labs develops cancer treatments designed to cross the blood-brain barrier and treat tumors in the central nervous system.
Generate BiomedicinesGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
Lavo Life SciencesLavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.
Dren BioDren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
Output BiosciencesOutput builds generative AI models trained on biological data to discover and develop medicines. The company focuses on applying large biological models to improve diagnosis, treatment, and disease prevention.
Transition BioTransition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease. The company is a platform-based biotherapeutics developer founded on academic research from the University of Cambridge.
Companies working in the same space as Diffuse Bio.
Legal entities · 1
corporate structureDiffuse Bio, Inc.
In the news
Frequently asked questions
- What does Diffuse Bio do?
- Diffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.
- Who founded Diffuse Bio?
- Diffuse Bio was founded by Namrata Anand in 2022.
- Who are Diffuse Bio's investors?
- Diffuse Bio's investors include GreatPoint Ventures, Humba Ventures, Virta Ventures, Y Combinator.
- Where is Diffuse Bio headquartered?
- Diffuse Bio is headquartered in San Francisco, US.